Market Place
Reply
1. Docetaxel (20 mg/ 2ml) Injection
2. Docetaxel (80 mg/ 4 ml) Injection
3. Docetaxel (160 mg/ 8 ml) Injection
4. Epirubicin (10 mg/ 5 ml) Injection
5. Epirubicin (50 mg/ 25 ml) Injection
6. Epirubicin (200 mg/ 100 ml) Injection
7. Irinotecan (20 mg/ ml) Injection
8. Paclitaxel (30 mg/ 5 ml) Injection
9. Paclitaxel (100 mg/ 7 ml) Injection
10. Paclitaxel (300 mg/ 50 ml) Injection
Comments :
sales1@vivindrugs.com
Dear Sir,
We have exclusive EUGMP Oncology FDF facility with 200+ products and most of them have EUCTD.
We can supply in 4-5 weeks lead time for all the products.
1. Docetaxel (20 mg/ 2ml) Injection
2. Docetaxel (80 mg/ 4 ml) Injection
3. Docetaxel (160 mg/ 8 ml) Injection
4. Epirubicin (10 mg/ 5 ml) Injection
5. Epirubicin (50 mg/ 25 ml) Injection
6. Epirubicin (200 mg/ 100 ml) Injection
7. Irinotecan (20 mg/ ml) Injection
Please feel free to contact for price and documents arunodayalabs@gmail.com
COA, Artwork, COPP, Packinsert, EUGMP, Product permissions and license will be shared once we have volumes.
service5@dragonpharm.com.cn
Hangzhou Dragonpharm can supply these FDFs.
haoran.tse@gmail.com
we can supply
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.?We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.?Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates ?Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.?vishvesh.shaishav@gmail.com
+919725487108
+919726387108
tautvydas@litfarma.com
Hello,
we are Litfarma company, EU Authorized Pharmaceutical Wholesaler based in Lithuania.
We are very active in Government Tenders and Hospital Supplies and have access to proprietary and generic medicines, medical devices, supplements - all authorized, certified, approved, notified or licensed in at least one EU country.
If your request is still valid, please get in touch with me directly at tautvydas@litfarma.com.
Thank you!
Tautvydas at @Litfarma Company
Lithuania, EU
